Myriad Genetics | MYGN - Current Assets

Stock Price
5.37
Daily Change
-0.10 -1.83%
Monthly
-12.54%
Yearly
-56.73%
Q1 Forecast
5.45

Myriad Genetics reported $344.8M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Agilent USD 4.59B 341M Sep/2025
Becton, Dickinson and Co. USD 9.26B 258M Sep/2025
Bio-Rad Laboratories USD 2.84B 30.9M Sep/2025
Bruker USD 2.35B 187.9M Sep/2025
Danaher USD 12.76B 3.15B Dec/2025
Exact Sciences USD 1.59B 82.87M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Illumina USD 2.8B 155M Sep/2025
J&J USD 54.61B 113M Sep/2025
Mettler Toledo International USD 1.28B 36.74M Sep/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
Quest Diagnostics USD 2.41B 209M Sep/2025
Quidel USD 1.37B 85.2M Sep/2025
Repligen USD 1.1B 39.62M Sep/2025
Revvity USD 2.14B 92.4M Sep/2025
Standard Biotools USD 472.44M 33.6M Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Veracyte USD 449.22M 34.54M Sep/2025
Waters USD 1.92B 137.07M Sep/2025